AstraZeneca (AZN) is a large-cap, research-driven pharma leader with broad growth across oncology, cardiovascular–renal–metabolism, and respiratory–immunology, supported by rising U.S. focus, robust trial wins, and steady dividend credentials. Therefore, if…

If you are looking for a simple, no-nonsense view on MSTR, here it is: the stock is a leveraged proxy on Bitcoin with a real, but smaller, enterprise analytics business…